KDM1A and breast cancer: Given the multifaceted functions of LSD1 in BC progression, new therapeutic strategies targeting LSD1 are constantly being developed, such as the discovery of novel LSD1 inhibitors, the development of dual-target inhibitors, and the combination therapies with chemical agents or immunomodulators (Kim et al., 2013; Boulding et al., 2018; Yang et al., 2018d; Qin et al., 2019; Verigos et al., 2019; Tu et al., 2020; Sobczak et al., 2022).